Will Little Subscribe

B2B Sales, NFTs, and PEG

Click here to view this email in your web browser 

Greetings everyone,

In this week’s episode of Ventures, my guests Steve Crepeau, Sol Cates, and I discuss the nuances of sales, including characteristics, values, tactics, and techniques for helping people progress along the buyer’s journey. Our discussion expands from complex B2B sales to how the “inflection point” concept can be applied to other areas of startups and enterprise sales, including “selling” your team and investors on your idea as a startup founder.

Check it out: Complex business-to-business (B2B) sales, the inflection point in a buyer’s journey, and strategies for building a sales team :: with Steve Crepeau and Sol Cates

Non-fungible tokens (NFTs)

For those not familiar with NFTs, The Verge recently published a great article: NFTs, explained. Beyond art, NFTs have practical applications such as tickets, movies, shoes, etc.. For better or worse, expect to hear a lot more about NFTs in the future.

Polyethylene Glycol (PEG)

This has come up pretty dramatically in the news recently because PEG is in the Moderna and Pfizer/BioNTech vaccines.  

I used PEG all the time during my years in a bioengineering lab. We’d use it for a wide range of basic things. It’s extremely common in drug delivery, and is used whenever you need a hydrophobic thing on one side and a hydrophilic thing on the other side, such as encapsulating mRNA to get safely to cells (vaccines).

It’s also extremely common in toothpaste, shampoo, and skin creams.

Some people are concerned that PEG in vaccines is causing allergic reactions. Scientists are looking into it, as apparently a very small fraction of people may have anti-PEG IgG antibodies that could potentially be triggering anaphylaxis. This is why being aware of allergies is important, and sticking around for 15m or so in case treatment is needed.

Have a great rest of your week!